Industry News
Pharmaceutical Industry News
Armed Bandits in Brazil Pursue New Loot: Ozempic
Criminals are targeting pharmacies and stealing weight-loss medication in a country with body image insecurities and where many cannot afford the drugs.
Medicare Doesn’t Pay for Everything: How to Bridge the Cost Gap
Older Americans have ways to protect against high out-of-pocket health care costs, but it’s important to understand the trade-offs.
The Pharmaceutical Industry Heads Into Elon Musk’s Wood Chipper
Who needs N.I.H. grants? A lot of red-state universities, for one.
¿Sirve la testosterona para las mujeres después de la menopausia?
La demanda de esta hormona está aumentando, y no solo para tratar la libido. Esto es lo que hay que saber.
Cuando los medicamentos para perder peso afectan a un matrimonio
Un cambio radical, en teoría positivo, podría representar el fin de la compatibilidad.
Dozens of Clinical Trials Have Been Frozen in Response to Trump’s USAID Order
The stop-work order on U.S.A.I.D.-funded research has left thousands of people with experimental drugs and devices in their bodies, with no access to monitoring or care.
Novo Nordisk Annual Sales Jump on Demand for Ozempic and Wegovy
The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower growth this year.
Testosterone Therapy for Menopause: What the Hormone Can, and Cannot, Do
Demand for the hormone is surging, and not just to treat libido. Here’s what we know about its benefits, and potential risks.
How an Activist Group Helped Torpedo MDMA Therapy
The fallout from the F.D.A.’s rejection of a new treatment for PTSD worries researchers and experts who fear other psychedelic drugs in the pipeline could be jeopardized.
Weight Loss Drugs and Their Lesser Known Side Effects on Relationships
Doctors warn about their physical side effects, but they can also have unexpected effects on intimacy.
Health Programs Shutter Around the World After Trump Pauses Foreign Aid
Lifesaving treatment and prevention programs for tuberculosis, malaria, H.I.V. and other diseases cannot access funds to continue work.
FDA Approves Journavx Drug to Treat Pain Without Addiction Risk
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.
Bernie Sanders and R.F.K. Jr. Clash Over Vaccines and Health Care
In a Senate hearing, Senator Bernie Sanders pushed Robert F. Kennedy Jr. again on his past support for unsupported claims that vaccines caused autism.
Pause on U.S. Funding Spreads Fear of H.I.V. Spike Across Africa
Patients and health care advocates said the abrupt decision to halt U.S. funding for a lifesaving H.I.V. program led to widespread confusion. The backtracking didn’t help.
Trump Administration Halts H.I.V. Drug Distribution in Poor Countries
PEPFAR’s computer systems also are being taken offline, a sign that the program may not return, as Republican critics had hoped.
New CVS App Lets Customers Unlock Cabinets to Pick Up Products
The company said the unlocking function, part of a pilot program in New York City, will be expanded this year.
F.D.A. Approves Ozempic to Treat Kidney Disease
The decision will further broaden the use of the blockbuster drug.
Would You Get Sick in the Name of Science?
Since the pandemic, drug trials that purposely make people vomit, shiver and ache have become a research area of growing interest. All that’s needed: brave volunteers.
Gazans Trek Home, and Trump’s Tariff Spat With Colombia
Plus, a Super Bowl three-peat?
In China, Government Data on Drugs Blocked From Public After Backlash
Criticism over how the Chinese government buys drugs for its public health care system has ignited frustration over the quality of medicine.